Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ankita Awase"'
Autor:
Manjunath Nookala Krishnamurthy, Gaurav Narula, Khushboo Gandhi, Ankita Awase, Ruta Pandit, Sunil Raut, Ritu Singh, Vikram Gota, Shripad Dinanath Banavali
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1009-1016 (2020)
PURPOSE Pegylated asparaginase is comparatively safer than native asparaginase in the management of acute lymphoblastic leukemia (ALL). However, the high price and nonavailability in low- and middle-income countries limits its use. In 2014, the first
Externí odkaz:
https://doaj.org/article/a6af9460e7aa4a18b64c7178f22328ba
Autor:
Jyoti Bhagatram Sharma, Manjunath Nookala Krishnamurthy, Ankita Awase, Amit Joshi, Vijay Patil, Vanita Noronha, Kumar Prabhash, Vikram Gota
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Aim: Accurate causality assessment (CA) of adverse events (AEs) is important in clinical research and routine clinical practice. The Naranjo scale (NS) used for CA lacks specificity, leading to a high rate of false positive causal associations. NS is
Externí odkaz:
https://doaj.org/article/2c222dd2ad8e4b1ab0fc89d738b12eb4
Autor:
Ido Lavi, Supriya Bhattacharya, Ankita Awase, Ola Orgil, Nir Avital, Guy Journo, Vyacheslav Gurevich, Meir Shamay
Kaposi’s sarcoma associated herpesvirus (KSHV, HHV-8) is associated with several human malignancies. During latency the viral genomes reside in the nucleus of infected cells as large non-integrated plasmids, known as episomes. All KSHV infected cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdee951a7ae37a71005d457434dac5d1
https://doi.org/10.1101/2021.10.10.463816
https://doi.org/10.1101/2021.10.10.463816
Autor:
Vanita Noronha, Kumar Prabhash, Jyoti Bhagatram Sharma, Amit Joshi, Vijay Patil, Manjunath Nookala Krishnamurthy, Vikram Gota, Ankita Awase
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
Aim: Accurate causality assessment (CA) of adverse events (AEs) is important in clinical research and routine clinical practice. The Naranjo scale (NS) used for CA lacks specificity, leading to a high rate of false positive causal associations. NS is
Autor:
Sharma, Jyoti Bhagatram, Manjunath Nookala Krishnamurthy, Ankita Awase, Joshi, Amit, Patil, Vijay, Noronha, Vanita, Prabhash, Kumar, Gota, Vikram
Supplemental material, sj-docx-1-taw-10.1177_2042098621991280 for Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy by Jyoti Bhagatr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1b7e6bec37915782ed9d48756df4a0
Autor:
Shripad Banavali, Sunil Raut, Vikram Gota, Gaurav Narula, Ritu Singh, Ankita Awase, Khushboo Gandhi, Manjunath Nookala Krishnamurthy, Ruta Pandit
Publikováno v:
JCO Global Oncology
PURPOSE Pegylated asparaginase is comparatively safer than native asparaginase in the management of acute lymphoblastic leukemia (ALL). However, the high price and nonavailability in low- and middle-income countries limits its use. In 2014, the first